An in vitro bioassay for quantification of melarsoprol in serum and cerebrospinal fluid.
A biological assay was developed for measuring melarsoprol in serum and cerebrospinal fluid of patients with human African trypanosomiasis. Trypanosomes were cultivated in microtiter plates for 72 hours with melarsoprol (Mel B) in concentrations of 1.25 micrograms/ml to 2.2 ng/ml. The minimum inhibitory concentration of Mel B for a reference Trypanosoma brucei rhodesiense clone was determined by microscopical examination. Samples of serum or cerebrospinal fluid were incubated under the same conditions and the highest dilution determined which caused death of all trypanosomes. The melarsoprol concentration of the sample was then calculated using the sample dilution and the determined minimal inhibitory concentration of the trypanosome population used for the assay. The test was validated using a number of reference samples and it was used for melarsoprol determination in serum- and cerebrospinal fluid samples taken from two treated patients. A sample size of 100 microliters was sufficient to perform the assay. The lower detection limit was 9 ng/ml (22.6 nmol/ml). The assay has potential for measuring other trypanocidal drugs in body fluids.
Burri
C
C
Swiss Tropical Institute, Basel.
Brun
R
R
D000818:Animals; D001681:Biological Assay / Q000379:methods*; D006801:Humans; D008297:Male; D008549:Melarsoprol / Q000097:blood* / Q000134:cerebrospinal fluid / Q000494:pharmacology / Q000627:therapeutic use; D016833:Trypanosoma brucei rhodesiense / Q000187:drug effects*; D014353:Trypanosomiasis, African / Q000097:blood* / Q000134:cerebrospinal fluid / Q000188:drug therapy
D008549:Melarsoprol